Suprachoroidal drug delivery promises targeted impact, but nothing comes without compromise. Formulation, delivery route and device design are tightly interlinked, with every decision shaping risk and reach.
David Cottenden from TTP’s Drug Delivery team explores how smarter delivery approaches can unlock the full potential of the suprachoroidal space.
About TTP's Drug Delivery team
TTP’s Drug Delivery experts specialise in designing and engineering advanced drug delivery systems and combination devices, solving complex formulation and delivery challenges, and engineering robust, scalable devices for diverse therapies and routes of administration.
Backed by a broader team of 350+ scientiss, engineers and human factors specialists, TTP enables reliable real-world performance and has contributed to more than 70 systems, spanning autoinjectors and inhalation devices through to microneedles, infusion pumps and advanced local-delivery platforms. Find out more.
